← Eichor
Study identifier: NCT05926596 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Leg Stretching Using an Exoskeleton on Demand for People With Spasticity

Condition: Spasticity · Movement Disorders · Spinal Cord Injury  ·  Sponsor: VA Office of Research and Development

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this research study is to develop a protocol using a fully wearable, portable lower-limb exoskeleton for improving leg and walking function in people with movement disorders. The study investigates the effects of wearing the device during a set of experiments including leg stretching, treadmill walking and overground walking in muscle activity, joint motion, and gait performance. The goal is to develop an effective lower-limb strategy to restore lost leg function (e.g., range of motion) and gait ability, and improve quality of life in people with movement deficits following a neurological disorder.

This description comes directly from the study's public registry record.

Talk to the study team

Steven W Brose  ·  (315) 425-4400  ·  steven.brose@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Syracuse VA Medical Center, Syracuse, NYSyracuse, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05926596